Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2007
Medialization thyroplasty for cancer-related unilateral vocal fold paralysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lam Paul K Y, Ho W K, Ng Manwa L, Wei William I
Аннотация
OBJECTIVE: To justify the application of medialization thyroplasty in Chinese patients with symptomatic cancer-related unilateral vocal fold paralysis (UVFP).
STUDY DESIGN AND SETTING: Retrospective chart review from February 2000 to March 2006.
RESULTS: Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040).
CONCLUSION: Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable.
SIGNIFICANCE: Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP.
STUDY DESIGN AND SETTING: Retrospective chart review from February 2000 to March 2006.
RESULTS: Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040).
CONCLUSION: Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable.
SIGNIFICANCE: Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP.
Предметные рубрики MeSH
AdultAge FactorsAgedAged, 80 and overAirway ObstructionDeglutitionDimethylpolysiloxanesFemaleHumansLaryngeal Nerve InjuriesMaleMiddle AgedNeoplasmsPolytetrafluoroethylenePostoperative ComplicationsProstheses and ImplantsRespiratory AspirationRetrospective StudiesSiliconesSpeechSurvival RateThyroid CartilageTreatment OutcomeVagus Nerve InjuriesVocal Cord Paralysis